Status:
SUSPENDED
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Lead Sponsor:
Mayo Clinic
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This study evaluates genetic testing to improve risk assessment and advance efforts to develop precision management for breast cancer by studying saliva samples for genotyping and evaluate association...
Detailed Description
PRIMARY OBJECTIVES: I. To collect saliva from 500 consenting women undergoing a clinically indicated breast biopsy, perform genotyping, and then assess the associations of polygenic risk score (PRS) ...
Eligibility Criteria
Inclusion
- \* Women over the age of 18 years
- Able to provide informed consent
- Referred for a radiologically guided breast biopsy
Exclusion
- \* Men
- Women under the age of 18 years
- Unable to provide informed consent
Key Trial Info
Start Date :
May 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06060561
Start Date
May 30 2023
End Date
June 30 2028
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980